Facebook
Twitter
Telegram
Report an ErrorAnika Therapeutics Cash Flow 2011-2024 | ANIK
Annual Cash Flow Anika Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.79 M | 4.41 M | 8.4 M | 13.1 M | 37 M | 34.9 M | 40.8 M | 24.4 M | 39.9 M | 40 M | 25.2 M | 10.5 M | 10.2 M |
Depreciation & Amortization |
6.43 M | 6.7 M | 6.48 M | 6.08 M | 4.96 M | 5.91 M | 4.29 M | 3.73 M | 3.78 M | 4.71 M | 4.77 M | 4.53 M | 4 M |
Accounts Payables |
9.86 M | 9.07 M | 7.63 M | 8.98 M | 3.83 M | 3.14 M | 6.75 M | 2.3 M | 8.3 M | 1.2 M | 2.79 M | 2.34 M | 4.3 M |
Accounts Receivables |
36 M | 34.6 M | 29.8 M | 24.1 M | 23.1 M | 20.8 M | 23.8 M | 27.6 M | 21.7 M | 17.2 M | 18.7 M | 21.5 M | 17.3 M |
Total Inventories |
46.4 M | 39.8 M | 36 M | 46.2 M | 22 M | 21.3 M | 22 M | 16 M | 14.9 M | 12.4 M | 11 M | 8.28 M | 7.3 M |
All numbers in USD currency
Quarterly Cash Flow Anika Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-126 K | - | - | -3.62 M | - | 3.93 M | - | -1.87 M | - | 3.92 M | - | -2.43 M | - | 10.5 M | 4.61 M | 1.04 M | - | 24 M | 13.9 M | 8.46 M | - | 24.9 M | 14.1 M | 9.59 M | - | 33.8 M | 21.7 M | 15.5 M | - | 18.4 M | - | 8.04 M | - | 23.8 M | 14.9 M | 3.98 M | - | 25.2 M | 17.8 M | 13.6 M | - | 17.2 M | 9.63 M | 6.07 M | - | 5.74 M | 3.53 M | -1.69 M | - | 2.87 M | -110 K | 1.29 M |
Depreciation & Amortization |
1.73 M | - | 2 M | 1.6 M | - | 4.98 M | 1.9 M | 1.67 M | - | 4.7 M | 2 M | 1.54 M | - | 4.54 M | 6.46 M | 2.76 M | - | 4.46 M | 2.94 M | 1.48 M | - | 4.43 M | 2.92 M | 1.47 M | - | 3.22 M | 2.02 M | 1.01 M | - | 2.78 M | 1.9 M | 942 K | - | 2.8 M | 1.83 M | 914 K | - | 3.58 M | 2.37 M | 1.2 M | - | 3.58 M | 2.27 M | 1.2 M | - | 3.36 M | 2.18 M | 987 K | - | 2.94 M | 1.94 M | 920 K |
Accounts Payables |
10 M | 9.86 M | 7.94 M | 8.95 M | 9.07 M | 8.35 M | - | 7.44 M | 7.63 M | 7.94 M | 8.1 M | 8.68 M | 8.98 M | 8.98 M | 8.98 M | 8.98 M | 3.83 M | 3.83 M | 3.83 M | 3.83 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 6.75 M | 6.75 M | 6.75 M | 6.75 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 2.79 M | 2.79 M | 2.79 M | 2.79 M | 2.34 M | 2.34 M | 2.34 M | 2.34 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M |
Accounts Receivables |
32.1 M | - | 36.7 M | 30.6 M | - | - | - | - | 29.8 M | 32.4 M | 29.4 M | 26.5 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M |
Total Inventories |
49.4 M | 46.4 M | 42.6 M | 41.3 M | 39.8 M | 37.2 M | - | 35.2 M | 36 M | 35 M | 42.9 M | 42.7 M | 46.2 M | 46.2 M | 46.2 M | 46.2 M | 22 M | 22 M | 22 M | 22 M | 21.3 M | 21.3 M | 21.3 M | 21.3 M | 22 M | 22 M | 22 M | 22 M | 16 M | 16 M | 16 M | 16 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 11 M | 11 M | 11 M | 11 M | 8.28 M | 8.28 M | 8.28 M | 8.28 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M |
All numbers in USD currency